Search
Tracking trust and suspicion: Analysis of social media to assist public health responses to Covid-19
How to promote acceptance, uptake, and adherence to public health measures for COVID-19 prevention and control? What are the most effective ways to address the underlying drivers of fear, anxieties, rumours, stigma regarding, and how to improve public knowledge, awareness, and trust during the respo
National database of SARS-CoV-2 infections (COVID-19) in pediatric oncology
Study of immune crosstalk in COVID-19
Coronavirus disease 2019 (COVID-19) is caused by «severe acute respiratory syndrome coronavirus 2« (SARS-CoV-2). First identified in 2019 in Wuhan, China, it has since spread globally, resulting in the pandemic. While the majority of cases result in mild symptoms, some progress to severe pneumonia a
Social and psychosocial determinants and consequences of the COVID19 epidemic and population confinement
Early in the pandemic, knowledge on the socio-economic and geographical determinants of COVID19 was lacking, limiting our understanding of which populations were most likely to become infected, hospitalised and die as a result of the infection. The lockdown measures put in place to control the epide
Covid-19 and Social Distanciation : Sujective time and socio-congitive reguaion of risk behaviours
Despite their highly strategic nature, social distancing measures are not necessarily respected, even when the health risks for each individual are scientifically proven, known and widely publicised. As some epidemiologists indicated, how individuals respond to government recommendations is at least
Observance and observation of barrier and containment measures: a behavioral economics approach
This project concerns the determinants of the propensity to adopt and follow the recommendations for prevention and containment in the face of the spread of Covid-19. The fundamental assumption is that this propensity is determined by the personal characteristics of the individual: one the one hand,
Immune response during Covid19 infection
Since March 2020, Europe has been facing the outbreak of the new coronavirus disease 2019 (COVID-19). This highly contagious infectious disease is a viral zoonosis caused by a virus SARS-CoV-2 from the coronavirus family that emerged in Wuhan in Chine in November 2019, causing first an epidemic that
Implementation of a fast and reliable assay for the high-throughput screening of antiviral molecules active against SARS-CoV-2
This year, the emergence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has led to an unprecedented pandemic termed Covid-19 (Coronavirus disease 2019). Even as human trials of candidate vaccines are already ongoing, there is still a doubt that people can develop protective immunity
Integrating sequence and incidence data to analyse and manage virus outbreaks
Understanding the spread of viral infectious diseases is central to informing public health decisions. Classical mathematical epidemiology primarily relies on incidence data (number of new cases per week) and contact tracing data. However, thanks to technological advances made in recent years, viral
Mathematical and computational modeling integrating real-time mobile phone data to evaluate interventions against COVID-19 pandemic in France
Not even 3 months after the first news of a pneumonic infection spreading from a food market in Wuhan, China, COVID-19 pandemic has moved epicenter from China to Europe. European countries, including France, are now facing a dramatic surge of cases that is already reaching hospital capacity in some
Covid-19 protein-protein interaction mapping
The identification of virus-virus and virus-host protein-protein interactions is a determinant element for the understanding of the mechanisms of replication and viral transmission. The knowledge of the molecular details of these protein interactions is a prerequisite for the discovery of new therap
COvid-19: Prevention Measures and Representations of Infection and Risk in the General Population
Since Covid-19 was first discovered in China and the WHO confirmed its human-to-human transmission, the French population has been kept informed by the media regarding the progression of the epidemy ‘til its arrival and development in France. Messages on the nature of individual prevention measures
Building a collective answer to the funerary challenges generated by the COVID-19 pandemic
COFUNERAIRE : building a collective answer to the funerary challenges generated by the COVID-19 pandemic The Covid-19 pandemic generates an unprecedented sanitary and social crisis. Numerous individuals are at the present time mobilized to respond to this crisis, among them actors of the funerary
Acoustic and Optic bioSensors for label-free CoVId-19 fast diagnosis
The world is currently facing a pandemic of a new emerging virus from the coronavirus family named COVID-19. Detection of infected patients is crucial to break the epidemic situation. As a consequence it is essential to diagnose fast and in large number populations to sort rapidly those who are infe
NSP3 polyprotein of SARS-CoV2: structural studies and its exploration in drug screening campaign
Severe Acute Respiratory syndrome (SARS) is an alarming emerging infectious disease caused by coronavirus (CoV). The current COVID-19 pandemic, which originated in the Wuhan region of China, is caused by a novel coronavirus, SARS-CoV2 which is more infectious than the 2003 SARS-CoV and which has led
Clinical proteomic characterization of the SARS-CoV-2 Spike protein to optimize its detection and the development of serological assays
Following the emergence and global spread of a new coronavirus called SARS-CoV-2, there is an urgent need to explore various aspects of this new disease, including its mode of transmission, virus-host interactions and immune response, diagnosis and therapy. This collaborative project leverages the c
Toward an integrated surveillance of potential zoonotic Betacoronaviruses in the wild animal value chain of Cambodia
Naturally hosted in wild animals such as bats, betacoronaviruses (beta-CoVs) are responsible for severe and fatal human respiratory infections. Data and knowledge on animal reservoir, but also knowledge on cultural, sociological and ecological factors driving beta-CoVs spread to humans and emergence
Behaviours and Experience of City Healthcare Professionals to the SARS-CoV-2 Epidemic
Given the overcrowding in hospital services, the management of the health crisis linked to the SARS-CoV-2 epidemic relies in particular on the Territorial Professional Health Communities, which include doctors, nurses and physiotherapists. The challenge of caring for patients in a health system desc
Guardian Angel COVID-19: a human and digital structure to facilitate the monitoring of patients suspected of or carrying COVID-19 in New Aquitaine
In order to assist city caregivers for the management of persons suspect of or affected by COVID-19 in the Nouvelle-Aquitaine region, we have built a device composed of a call and mailing platform to answer practical questions, a web application to survey patients at home associated with a platform
Prospective assessment of severity predictive criteria for patient calling at a dispatching center (SAMU-centre 15) for low or high respiratory infection with or without fever suspected of COVID-19 infection.
The COVID-19 epidemic that emerged in China in December 2019 has spread pandemically around the world. At this time, France has recorded 16,689 confirmed cases of SARS-CoV2 and 614 deaths. In the Occitania region, 86 patients are hospitalized in intensive care units for severe pulmonary disease. In
Real-time blood transcriptomic of COVID-19 patient
The COVID-19 epidemic is spreading massively. This virus being new, the questions of diagnosis, prognosis, choice of treatment and pathophysiology are open. The aim is to generate standardized, real-time transcriptome data from whole blood of COVID patients, looking for diagnostic, prognostic and p
Nanoformulations of current therapeutic drug candidates against SARS-CoV-2 for pulmonary delivery
Therapeutic options in response to the SARS-Cov-2 outbreak are urgently needed and existing one are still limited. Facing pandemic development, actual strategy has been to repurpose some existing antiviral drugs used against respiratory diseases (SARS-Cov-1, MERS, Influenza) or chronic diseases (HIV
COVID-19: Clinical Ethical Issues During and After Pandemia. Stakeholders perspectives.
The COVID-19 pandemic is deeply destabilizing countries and their organizations, particularly in the healthcare field. Likewise, the usual ethical standards in the medical field are being disrupted. Such disruption causes anxiety or disarray among healthcare professionals, patients and their familie
Rights of Marginalized during the Coronavirus Crisis: Hospitality and Commitment
The lockdown instituted by the government in March 2020 has affected the role of social actors involved with exiled people. Many associations have been alerted to the situations experienced by individuals in precarious situations. As researchers involved in the associative field in Rennes, we wonde
Chinese migration in France facing Covid-19: the emergence of new forms of solidarity in times of crisis
This project aims to analyse the representations, perceptions, attitudes and behaviours related to Covid-19 through the prism of Chinese migration in France. Some of them - medical experts, journalists, association leaders, researchers - are, as of January 2020, actively involved in the organization
Role of the microbiota in the evolution of the SARS-CoV-2 disease in hospitalized patients
Patients hospitalized for COVID-19 may need intensive care (e.g. mechanical ventilation) during hospitalization. Some risk factors are already known (e.g. sex, comorbidities, initial clinical presentation inflammatory cytokines), but better targeting of such patients is still needed, at least becaus
Interventions for Covid-19 infection: a living mapping of research and a series of living network meta-analyses
Context: In December 2019, a novel coronavirus outbreak was documented in Wuhan, Hubei Province, China. Over the first 6 weeks of the new decade, this novel coronavirus, known as SARS-CoV-2, has spread from China to 20 other countries and WHO recently characterized Covid-19 as a pandemic. To overcom
Polyanion delivery and protection systems against viral infections
Current outbreak of SARS-CoV-2 virus and its social, health and economic impact put forward the need for i) potentially generic protection system that can be applied to both surfaces and persons to limit/eliminate transmission during the exponential phase of the outbreaks; ii) development of predict
REpresentations, PErceptions and Attitudes to the COVID-19 virus
The general proposal aims at investigating the representations, attitudes and reactions of public opinion in a context of the COVID-19 epidemic through a variety of countries differently exposed to the coronavirus. Contrary to conventional research projects, REPEAT has been conceived to be implement
Accelerated Structural Genomics on CoViD-19
Starting late December 2019, the emergence of an uncharacterized pathogen appeared from the city of Wuhan, China. Since then, the identified CoViD-19 virus propagated worldwide, infecting tens of thousands of humans and killing thousands. The countries suffering the most from the infectious disease
Natural History of SARS-CoV2 : Emergence and Reservoir
In late December 2019, a new disease named COVID-19 (COronaVirus Infectious Disease 2019), due to a new Betacoronavirus, the SARS-CoV-2, was notified in Wuhan, China. WHO declares “A public health emergency of international concern” on January 30th, 2020. A few weeks later, the virus has spread in m
Regulating Wetmarkets in Central China : Ethnographic Study of the Perception of Zoonotic Risks after the Covid-19 Crisis
Our consortium of French and Chinese social anthropologists will investigate the impact of the Covid-19 crisis on the regulation of wetmarkets in central China. Based on our expertise in the anthropology of human-animal relations in various societies and in the ethnography of the reconstruction of d
Dual Profiling of the SARS-CoV2 interplay With the INnate immune response pathway
COVID-19 has emerged in December 2019 in Wuhan, China, caused by a novel RNA virus: SARS-CoV-2. As of March 22 2020, ~300,000 cases of COVID-19 and nearly 12,000 deaths (fatality rate ~4%) have been reported in the world. The high proportion of cases requiring respiratory assistance in intensive car
Handwashing as a behavioral challenge in the fight against Covid-19
The goal of this proposal is not to find a vaccine, it isn’t to find a treatment either. The goal of this proposal is to learn how to deal with an epidemic in the absence of vaccines and treatment. In such circumstances, the only lever that is left for policy makers is to act on citizens’ behavior.
The role of the Army in the "war" against the coronavirus and its perception by the population
This proposal aims at questioning the mobilization of the military in the fight against the coronavirus, designated as an "invisible enemy". The objective of the project is twofold. On the one hand, it analyzes the decision-making process within the political institutions of the State and the Army
Social distancing and pro-sociality in times of acute sanitary crisis
This project belongs to the priority “Ethics -Human and Social Sciences” and the topic “Representations, perceptions, attitudes, behavior relative to the epidemic”. Context. To stop the current coronavirus pandemic, the governments of most developed countries are implementing drastic measures to
Electrospun fabric with anti-infectious activity for the manufacturing of respiratory masks
Respiratory masks are individual protection devices of high strategic value of national and international stakes in the fight against viral bacterial and fungial diseases. Classical respiratory masks used for the protection of civil population and medical staff are adapted for efficiently filtrate a
COVID19 & Lockdown: a Longitudinal Survey.
Analyses of the health crises which have occurred in recent decades showed that they were also social, economic and political crises which were notably fed by uncertainties about actual severity of the risk, health consequences to be feared, duration of the crisis, or reactions of the population. Pu
An agent-based spatial temporal stochastic framework for modeling of epidemic spread and interventions
Numerous epidemic models have been implemented to study epidemic spread in time and space. Most are of compartment type [REFS]. The increase of computational speed over the last decades make it possible to implement and study sophisticated models by massive computer simulations that can then be cal
A TARGETED METABOMOLIC APPROACH TO DESIGN A PREDICTIVE MODEL FROM THE MONITORING OF THE INFLAMMATORY MEDIATORS KINETICS IN PATIENTS ADMITTED TO INTENSIVE CARE UNIT WITH COVID-19 PNEUMONIA.
Beginning in December 2019, a novel coronavirus, designated SARS-CoV-2, has caused an international outbreak of respiratory illness termed Covid-19, requiring for a small proportion of patients, admission to Intensive Care Unit (ICU). However, despite the urgent needs of therapeutic guidelines, litt
NOsocomial Dissemination risk of SARS-Cov2
The ultimate aim of this project is to provide simulations of the risk of nosocomial spread of SARS-Cov2 in French hospitals as quickly as possible (within a few weeks). We will use investigation method, analysis and simulation tools derived from research works carried out in the field of multidrug
COVID 19 Rapid diagnosis test (development and clinical validation in 7 weeks)
COVID-19 is an acute respiratory disease caused by novel coronavirus SARS-CoV-2 also known as 2019-nCoV. On March 11, 2020, the World Health Organization (WHO) characterized COVID-19 as a pandemic. The disease is spreading worldwide. The World Health Organization has declared a global health emergen
Containment and health measures to limit COVID-19 transmission: Social experiences in France, Italy and the USA in the time of a pandemic
COMESCOV complements the AEC2-France project funded by REACTing. It is part of two axes of the ANR call: human and social dimensions of the response; preventive measures in health care settings and in population. The objective is to document and analyse the social experience of sanitary measures (
" Pull on the masks ?" Socio-economic study of face masks during the Covid-19 pandemic
The purpose of the MASKOVID project is to examine, from a social science point of view, the contribution of masks as a tool to combat the virus, among other possible means. Covid-19 poses an unprecedented challenge in terms of health protection: in the absence of a vaccine and specific drugs, other
Characterization of inflammatory responses by host transcriptomics and coinfections by metagenomics in order to understand the excess mortality of patients with COVID-19 with ARDS in intensive care
Pandemic SARS-CoV-2 (COVID-19) respiratory infection is responsible for more than 4,000 deaths, mainly (67%) secondary to acute respiratory distress syndromes (ARDS) (Yang 2020) . ARDS is usually associated with a mortality of around 40% (Gilbert 2018), but this rate reaches 61% in patients infected
Simulation platform for assessment and improvement of control measures against diffusion of SARS-CoV-2 in nursing homes and long-term care facilities
Background: The current COVID-19 outbreak could be devastating among dependent elderly people housed in nursing homes and long-term care facilities (NHLTFs) given the intensity of contacts (between residents and between residents and staff) and the difficulty to identify infection in this elderly po
Health, Perception, Practices, Relationships and Social Inequalities in the General Population during the Crisis COVID-19
The SAPRIS project aims to conduct a general population survey to understand the main epidemiological and social issues of the SARS-CoV2 epidemic. In particular, the understanding and implementation of prevention measures, the perception of risk for oneself and in general, the prevalence of symptoms
Prospective analysis of morbi-mortality of patients with cancers in active phase of medical treatment suspected or diagnosed of a SARS-COV2 infection.
Since December 2019, the novel coronavirus (SRAS-COV2, causing an emerging infectious disease called COVID-19) has spread quickly worldwide. As of Mar 16th 2020, 165 000 cases and 6 500 deaths have been reported over 146 countries (WHO data). In Europe, Italy, Spain, France and Germany are currently
Pull the COVID-19 replicative catalytic core apart
Antiviral strategies targeting replication machineries have proven their efficacy, with as gold example the cure of HCV patients and to a lesser extent the HIV treatments that control viral load. One of the prerequisites is a detailed knowledge of the structure and function of the multi-protein repl
Inborn errors of immunity underlying life-threatening COVID-19 in previously healthy patients
The major role of human genetic variability in immunity to infection is now well established, in particular for viral infections. We have identified a number of monogenic inborn errors of immunity (IEIs) underlying life-threatening viral diseases, such as herpes simplex virus encephalitis, fulminant
Lessons learned from the resilience of hospitals and staff to the COVID-19 pandemic
Beyond biomedical research, it is imperative that the SARS-CoV-2 pandemic be studied in terms of its impact on health systems, including health professionals. Indeed, all public health efforts currently being implemented in France and elsewhere are aimed at reducing the burden of COVID-19 on fragile
Development of mouse models of COVID-19
Research on COVID-19 is currently hampered by the delayed availability and lack of diversity of small rodent models of SARS-CoV-2 infection. Wildtype mice are poorly susceptible to this virus due to the sequence divergence between the mouse and the human in the ACE2 gene which acts as the virus rece
Economic Epidemiology of Covid-19
ECOVID-19 aims to provide a comparative cost-effectiveness analysis (CEA) of public policies undertaken in real-life conditions during the Covid-19 epidemic in France. We will compare three main measures: i) confinement measures ii) testing with a specific focus on undocumented infections iii) remin
Role of SARS-CoV-2-infected pulmonary cells and antibody response in COVID-19 outcomes: From pathophysiology to testing candidate drugs in mucosal cell models
Background: The emerging SARS (Severe Acute Respiratory Syndrome)-CoV (Corona virus)-2 is a novel airborne coronavirus threatening public health that is currently spreading worldwide causing the severe respiratory syndrome known as COVID-19 1, for which no treatment is yet available. One of the rel
Potential HLA class I associations with COVID-19 control
Whether host genetic determinants influence the susceptibility to and severity of COVID-19 is unknown. Cytotoxic T cells recognize virus-infected cells after presentation of short viral peptides within the binding groove of HLA class 1 (HLA-1) molecules. NK cells also recognize virus-infected cells
Acute Immune response and Omics analysis in Covid19 infection: molecular rationale for targeted therapies
As of March 23rd 2020, the COVID-19 outbreak is affecting > 340,000 people worldwide, carrying a mortality rate ranging from 1/1000 in some countries but reaching several % in others. This variability may result from the rate of detection which differs in these countries, but it also relies on the
Pathogenesis of SARS-Cov-2 infection in NHP model: insights for treatment and prevention
AM-COV-Path aims at the development of a non-human primate model of the SArS-CoV-2 infection and disease. We will use this model to study the mechanisms of transmission and pathogenesis, focusing on dynamics of viral dissemination, the associated tissue damages in the respiratory tract and at sites
Trust in science and public institutions challenged by Covid-19
How can we find the right words and arguments to convince the population to adopt behaviors that are healthful, not on an individual basis but in the name of the general interest? The CIESCO project aims to understand the conditions of reception and acceptance of speeches made by government offici
Quantification and spread of SARS-CoV-2 in the surrounding air and fomites of patients suffering from COVID-19
Rationale. Recommended infection control precautions for COVID-19 include the use surgical mask in most care situations, for limiting the contamination of mucosa by large droplets. However, several invasive respiratory procedures can generate aerosols of small particles, requiring the use of a N95 o
Viral dynamics at the individual and population levels: impact for antiviral treatment optimization
The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which originat-ed in Wuhan, China, has become pandemic and a major concern all over the world. By March 22, 2020, this virus has a?ected more than 320,000 people worldwide and caused more than 14,000 deaths. Despite the un
Umbilical cord-derived mesenchymal stromal cells therapy in SARS-CoV-2-related ARDS
Whereas the pandemic due do Covid-19 continues to spread, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes Severe Acute Respiratory Distress Syndrome in 30% of patients with a 30%-60% mortality rate for those requiring hospitalization in an intensive care unit. The main physio
Household transmission investigation study for SARS-CoV-2 in French Guiana
Since December 2019, a new coronavirus, SARS-CoV-2, has been identified in the city of Wuhan in China. By 22 March 2020, the virus had spread to all continents, causing 294 110 confirmed cases and 12 944 deaths worldwide. The detection and spread of this emerging respiratory pathogen are accompanied
Nucleic-based rapid and portable diagnostics of COVID19.
Since the outbreak of Ebola, in 2014, MMN-ESPCI and CIBU-PASTEUR have worked together to develop a portable test, dedicated to the detection of nucleic acids of pathogens, viruses and bacteria, exploiting the latest developments of microfluidic paper technology and molecular diagnostics. Together, w
Seroconversion Sars-CoV2 among healthcare professionals working in front-line departments for the care of patients infected with Covid-19 during the 2020 epidemic
The epidemic due to the Sars-CoV2 virus is spreading in France with an increasing number of affected patients. The medical and paramedical staff of the front-line departments for the care of patients infected with Covid-19 are potentially exposed to the risk of occupational contamination due to the
Developement of a rapid test for screening and charaterization of immune response against the Sars-Cov-2 virus
On 03-11-2020, the WHO declared a pandemic, due to an emerging betacoronavirus identified in China on 12-31-2019, named SARS-CoV-2. Responsible of the COVID19 syndrome, this virus induces a pathology which clinical spectrum ranges from asymptomatic cases to the occurrence of ARDS. Molecular biology
Attitudes and health behaviours of the elderly facing the COVID-19 crisis: a prospective survey in general population.
Faced with health crises, the elderly are among the most at risk, as the 2003 heat wave in French has shown, excess mortality related to age being particularly marked in people living alone or in nursing homes. Even though the COVID-19 epidemic is far from over, it is more than likely that the elder
Digital Epidemiology: Analysis of social network contents to anticipate fluctuations in transmission intensity and confinement efficiency of the SARS-COV2
The propagation of the SARS-COV2 in France has completely overloaded health facilities until producing an unprecedented confinement on our territory. In order to mitigate as much as possible sanitary and economic consequences, it is mandatory to try anticipating the level of local transmission and t
Blood donor population and CoV-2 SARS studies: Epidemiology, natural history, human and social sciences and therapeutics
French blood donor population contribution to SARS-CoV-2 studies: epidemiology, natural history, human & social sciences and therapy Acronym: COVIDonneur This project addresses the topics "Epidemiological and translational studies" and "Ethics - Human and social sciences associated with
"Fabricating ethics in times of pandemic crisis. Anticipation, trust, innovation "
This research proposal falls within the field of ethics, understood as a transversal and interdisciplinary reflection aimed at clarifying the "moral motives" of our actions (values, norms, purposes, consequences). The particularity of our approach is to place this reflection as close as possible to
Systemic and mucosal immune response variation during SARS-CoV-2 infection and recovery
Coronavirus disease (COVID-19) is an infectious disease that primarily targets the human respiratory system and is caused by a novel virus denoted ‘Severe Acute Respiratory Syndrome coronavirus 2’ (SARS-CoV-2). The immune response to SARS-CoV-2 is the primary cause of the lung pathology and associat
AiR mOnitoring high-riSk area: Air monitoring of coronaviruses (SARS-CoV2) presence in high-risk area
The ARISE project will produce an air analyser equipped with detection capabilities for the ubiquitous monitoring of airborne SARS-CoV-2 pathogens to monitor confined environments. COVID-19 is a recently occurring disease caused by the SARS-CoV-2 coronavirus. Its spreading is rapid and hard to cont
Fast, simple and enzyme-free detection of SARS-CoV-2
COVID-19 has reached a pandemic scale in a few months and is devastating the heath systems of many nations. Knowledge of the virus is still parcelar, but asymptomatic but infectious carriers appear to be driving the explosive growth of the disease. In absence of a vaccine, the best way to manage the
Home treatment of people infected with SARS-CoV-2 without signs of severity but at risk of complications: a randomized multi-arm, multi-stage trial (MAMS) to evaluate the efficacy of several antivirals
Optimizing home treatment for patients with COVID-19 and risk factors for aggravation could reduce hospitals' workload and improve individual outcomes. This is one of the biggest challenges to be met in the coming weeks. We propose a trial to compare possible drugs for this indication to the curren
Lysotropic agents for the treatment of COVID-19 : azithromycin, chloroquine and hydroxychloroquine
Lysosomotropic agents for the treatment of COVID-19: azithromycin, chloroquine and hydroxychloroquine Phase II clinical trials have led to the preliminary conclusion that chloroquine, hydroxychloroquine and azithromycin may reduce the viral load in patients with COVID-19, spurring the launch of m
Development of tests for the diagnosis of Covid-19
In order to address the health crisis around the SARS-CoV-2 infection, there is a growing need and demand for diagnostic tools that are complementary and different from the RT-PCR currently in use. Moreover, in view of the worldwide demand for testing, it is important to have new tools and tests pro
Coping with Covid-19: Social Distancing, Cohesion, and Inequality in 2020 France
To tackle the spread of the Covid-19 epidemic, governments have imposed new and unprecedented rules of social life, which have disrupted everyday practices and may have profound effects on different segments of the population. We will assess the social effects of the epidemic and confinement in Fran
An automated, simple, affordable and robust system allowing the diagnosis of Covid-19 at home or in a medical service, by a non-specialist operator, from a saliva sample.
The W-covid project consists in designing an automated, simple, economical and robust system allowing the diagnosis of covid-19 at home or in a medical service, by an non-specialist operator, using a saliva swab. The system consists of three main parts: - a consumable pre-filled tube for saliva
Engineering nanobinders to block SARS-CoV-2 entry
The novel coronavirus SARS-CoV-2 has recently emerged as a human pathogen in China’s Hubei province, causing severe respiratory illness and pneumonia. According to the World Health Organization (WHO) on March 17th, 2020, there have been over 180,000 cases globally, leading to at least 7,500 deaths.
Clinical and virological course of COVID-19 patients seen in primary care consultation
Current knowledge of the natural history of COVID-19 is mainly based on the description of hospitalized cases, but, to our best knowledge, no data has been reported from the general population. In agreement with the COVID-19 research priorities identified by the WHO, and with the research topics tar
Initial COVID-19-associated SARS-CoV-2 Cell Atlas and Response
The recent outbreak of pneumonia-inducing and potentially lethal COVID-19 has become a major world-wide public health issue with dramatic societal and economical consequences. The SARS-CoV-2-inducing COVID-19 belongs to the Betacoronavirus family, and is close to the previously emerged SARS-CoV and
Immunopathology of Covid-19 in Assistance Publique hospitals of Paris
An exceptional effort to constitute a biobank of blood samples from patients with COVID-19, admitted to the hospital wards of the Public Hospitals in Paris (Assistance Publique-Hôpitaux de Paris: AP-HP), will be undertaken as an emergency measure, starting on March 23, 2020 with all regulatory and e
Impact of COVID-19 epidemic and quarantine on mental health and addictive behaviors in the community – a study nested in the TEMPO cohort
The occurrence of an infectious disease epidemic, such as the one caused by the Covid-19 virus can be a source not only of morbidity and mortality, but also considerable disruptions in people's lives, causing psychological, social and economic damage. In terms of mental health, research based on rec